Buprenorphine buccal film for chronic pain management

Written by Martin Hale, Joseph Gimbel & Richard Rauck

Buprenorphine is an opioid with effective analgesic properties and fewer safety risks than other opioids. This paper focuses on the buccal film formulation and, based on the newest clinical studies, evaluates why it is preferable to other buprenorphine formulations due to its bioavailability, safety and efficacy advantages. Buprenorphine buccal film offers effective and continuous pain relief that is generally well tolerated, with no cases of respiratory depression reported in any of the studies. Clinicians should consider utilizing buprenorphine buccal film as a first-line opioid treatment for chronic pain over other buprenorphine formulations or other opioids.

A recent Drug Evaluation published in Pain Management reviews the latest clinical data available for buprenorphine buccal film in chronic pain management.

View the full article